Patent · US Active

Alpha-v beta-6 integrin ligands and uses thereof

US12173086B2 · kind B2 · utility

0Cited by

3References

15Claims

0Family size

Assignee

Arrowhead Pharmaceuticals, Inc. · US

Inventors

Aaron Almeida · Madison, US
Zhen Li · Westfield, US
Erik W. Bush · Verona, US
Tao Pei · Morganville, US
Agnieszka Glebocka · Madison, US
Anthony Nicholas · Oregon, US
Jeffrey C. Carlson · Madison, US
Matthew Fowler-Watters · Madison, US

Key dates

Filing date	Oct 14, 2021
Grant date	Dec 24, 2024
Priority date	—
Expiry date	Nov 6, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Integrin ligands having serum stability and affinity for αvβ6 integrins are described. Compositions comprising αvβ6 integrin ligands having serum stability and having affinity for αvβ6 integrins and methods of using them are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.